1. Rationale and Clinical Research Progress on PD-1/PD-L1-Based Immunotherapy for Metastatic Triple-Negative Breast Cancer
    Yifan Ren et al, 2022, International Journal of Molecular Sciences CrossRef
  2. The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wei Wang et al, 2022, Clinical and Translational Oncology CrossRef